RI
BMY icon

Rudd International’s Bristol-Myers Squibb BMY Stock Holding History

Rudd International’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		$265K Buy
4,522
+300
+7% +$17.9K 0.14% 61
2020
Q1 		$235K Hold
4,222
– – 0.15% 62
2019
Q4 		$271K Buy
+4,222
New +$242K 0.14% 63
2019
Q3 		– Sell
-4,748
Closed -$215K – 76
2019
Q2 		$215K Buy
+4,748
New +$221K 0.12% 73

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Rudd International's BMY Position: Q2 2020 in Review

Rudd International increased its Bristol-Myers Squibb (BMY) stake by 7.1% in Q2 2020, buying an estimated $17.9K and bringing the position to 4,522 shares worth $265K. The position accounts for 0.14% of the portfolio, ranked #61.

Rudd International first reported a position in BMY in Q2 2019 and has held it in 4 quarters since. The position peaked at $271K in Q4 2019. 2,189 funds tracked by Wall St. Rank hold BMY as of Q2 2020.

  • Rudd International held 4,522 shares of Bristol-Myers Squibb worth $265K as of Q2 2020.
  • Rudd International bought 300 Bristol-Myers Squibb shares in Q2 2020, an estimated $17.9K.
  • Bristol-Myers Squibb made up 0.14% of Rudd International's portfolio in Q2 2020, its #61 holding.
  • Rudd International first reported a position in Bristol-Myers Squibb in Q2 2019 and has held it in 4 quarters since.
  • Rudd International's Bristol-Myers Squibb position peaked at $271K in Q4 2019.
  • 2,189 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2020.

Based on Rudd International's 13F filing for Q2 2020, filed 4 Aug 2020.